Skip to main content
Home
Home
  • Position paper 2025
  • About us
    • Our mission & values
    • Meet the team
    • Our story
    • Board of Directors & Governance
    • Annual Report & Transparency
    • Partners & Network
  • Contact us
  • EN
  • NL
  • FR
  • Clinical research
    • Our research focus
    • Our clinical trials
    • Science office
    • Policy hub
  • Patient support
    • My Cancer Navigator
  • News
    • News releases
    • Blogs
  • Sponsors & donors
  • Get involved
    • Make a donation
    • Bank account information
    • Sponsorship & pledged giving
    • Maximise your tax benefit
    • Leave a legacy
Donate
  1. Home
  2. Trials
  • Brain cancer (2)
  • Breast cancer (2)
  • Melanoma (2)
  • Blood cancer (1)
  • Gynaecological cancer (1)
  • Lung cancer (1)
  • Paediatric cancer (1)
  • Sarcoma (1)
  • Solid tumours (1)
  • Ongoing, not recruiting (2)
  • Recruiting (7)
  • (-) Completed (12)
  • Terminated (9)
  • (-) All Periods
  • 2020
  • 2019
  • 2017

Trials

Trial Title Status Cancer types
PROPANGIO
Neoadjuvant β-blocker in angiosarcoma patients
Completed Sarcoma
DCA in GBM
Study of the Safety and Efficacy of Dichloroacetate in Glioblastoma and Other Recurrent Brain Tumours
Completed Brain cancer
ImmunoPAX
Study of ultra-low dose paclitaxel in metastatic melanoma
Completed Melanoma
ViDME
Vitamin D treatment for melanoma
Completed Melanoma
PRIMMO
Immunotherapy, radiation and an immune modulatory combination in cervical and uterine cancer
Completed Gynaecological cancer
BOOST YOUR MIND
Mindfulness after cancer treatment
Completed Blood cancer
PIONEER
Pre-operative hormone treatment for ER+ breast cancer patients
Completed Breast cancer
Nitroglycerin MAASTRO
Repurposing angina pectoris medication as lung cancer treatment
Completed Lung cancer
METZOLIMOS
Advanced bone cancer treatment with a combination of chemotherapy and immunosuppressants
Completed Solid tumours

Pagination

  • Current page 1
  • Page 2
  • Next page ›
  • Last page ››
Logo

Brusselsesteenweg 11 1860 Meise +32 (0)2 268 48 16

Happy to hear from you

Please contact us about anything related to our foundation or work.

Contact us

Sign up for updates

Subscribe

  • Disclaimer
  • Sitemap
  • Privacy Policy
  • Copyright Anticancer Fund 2024
Follow us: